US pharmaceutical giant Johnson & Johnson has started human trials on a possible vaccine against Ebola.
US pharmaceutical giant Johnson & Johnson has started human trials on a possible vaccine against Ebola. The company is hoping to move on to studies on large groups of patients by April.
The Oxford Vaccine Group at Britain's Oxford University is carrying out Phase I testing of the Ebola vaccine. 72 healthy volunteers are part of the test that will examine how their bodies tolerate the potential vaccine.
Ebola Virus Disease | Ebola Hemorrhagic Fever: Cause Symptoms Diagnosis Treatment
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have identified five types of Ebola or Ebola hemorrhagic fever virus.
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have identified five types of Ebola or Ebola hemorrhagic fever virus.
Source-Medindia
British Ebola Nurse Critical but in Stable Condition
A British nurse, Pauline Cafferkey, who is being treated for Ebola at London's Royal Free hospital, is in a critical but stable condition, reported Britain's health minister.
A British nurse, Pauline Cafferkey, who is being treated for Ebola at London's Royal Free hospital, is in a critical but stable condition, reported Britain's health minister.
Government of Somalia Dismisses Rumors of Ebola Outbreak
The government of Somalia has reassured its' residents that there was no outbreak of Ebola in the country.
The government of Somalia has reassured its' residents that there was no outbreak of Ebola in the country.
Ebola Outbreak Will End in 2015
Anthony Banbury, the outgoing head of the United Nations Ebola Emergency Response (UNMEER) has said that the disease will be ended in 2015.
Anthony Banbury, the outgoing head of the United Nations Ebola Emergency Response (UNMEER) has said that the disease will be ended in 2015.
